- Open Access
Safety of exercise training in multiple sclerosis: a protocol for an updated systematic review and meta-analysis
Systematic Reviews volume 10, Article number: 208 (2021)
There has been an exponential growth in the number of clinical research studies regarding exercise training in multiple sclerosis, and literature reviews and meta-analyses have documented the many benefits of exercise training. This research further requires careful review for documenting the safety of exercise training in multiple sclerosis, as clarity on safety represents a major hurdle in the clinical prescription of exercise behaviour.
To enhance understanding of the feasibility of exercise in multiple sclerosis, we (1) provide a protocol of a systematic review and meta-analysis that summarises rates and risks of clinical relapse, adverse events (i.e., an unfavourable outcome that occurs during the intervention delivery time period), and serious adverse events (i.e., an untoward occurrence that results in death or is life threatening, requires hospitalisation, or results in disability during the intervention delivery time period), as well as retention, adherence, and compliance, from randomised controlled trials of exercise training in persons with multiple sclerosis; and (2) identify moderators of relapse, adverse events, and serious adverse event rates.
Eight field-relevant databases will be searched electronically. Studies that involve a randomised controlled trial of exercise training (with non-exercise, non-pharmacological, comparator), report on safety outcomes, and include adults with multiple sclerosis will be included. Rates and relative risks of the three primary outcomes (relapse, adverse event, and serious adverse event) will be calculated and reported each with standard error and 95% confidence interval. Random-effects meta-analysis will estimate mean population relative risk for outcomes. Potential sources of variability, including participant characteristics, features of the exercise stimulus, and comparison condition, will be examined with random-effects meta-regression with maximum likelihood estimation.
The results from this systematic review and meta-analysis will inform and guide healthcare practitioners, researchers, and policymakers on the safety of exercise training in persons with multiple sclerosis. Where possible, we will identify the impact of exercise type, exercise delivery style, participant disability level, and the prescription of exercise guidelines, on the safety of exercise training. The result will identify critical information on the safety of exercise in persons with multiple sclerosis, while also identifying gaps in research and setting priorities for future enquiries.
Systematic review registration
PROSPERO 2020 CRD42020190544
Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system (CNS) with no known cure . There has been an estimated 10% increase in the global prevalence of MS in the last two decades , with estimates indicating MS now affects over 2.8 million people globally , with one million cases in the USA alone . MS is the most common non-traumatic disabling disease among young adults and is more common in females . The underlying cause of the disease is unknown, and the disease follows a relapsing-remitting clinical trajectory in the majority of cases. MS commonly results in cumulative and heterogeneous physical and cognitive disability, as well as debilitating symptoms such as fatigue, depression, and pain . The health burden is high such that the 2016 Global Burden of Disease study reported that over 1.1 million disability-adjusted life-years were attributable to MS .
The burden of MS has both personal and societal impacts, and this extends into participation in optimal health behaviours, such as exercise participation. Upwards of 80% of persons with MS do not engage in sufficient amounts of exercise necessary for health-related benefits . Exercise training represents the salient approach to symptom management, and safe approaches to increase and maintain exercise practices should be promoted among persons with MS throughout the disease trajectory [8, 9].
Optimal health and wellness are of high priority for people with MS [10, 11], and persons with MS can achieve optimal health through positive health behaviours, particularly participation in exercise. Exercise is commonly included in rehabilitation programmes addressing the functional impairments associated with MS ; exercise is widely considered to be an essential strategy in the clinical management of MS . Over three decades of scientific enquiry have established the many health benefits of exercise training in persons with MS . Systematic reviews and meta-analysis have concluded that exercise training can improve physical fitness and walking mobility [15, 16], balance , cognition , fatigue , depressive symptoms [20,21,22], and quality of life . There is evidence indicating that exercise has a positive effect on the hippocampus [23, 24], sleep quality [25, 26], and cardiovascular and metabolic comorbidity [27, 28]. The volume and quality of research output on exercise in MS populations has increased substantially in recent years .
There further is a shift in the clinical landscape surrounding exercise prescription in MS. This is based on the first clinical exercise guidelines for persons with mild-to-moderate MS that were published in 2013 [19, 29], and have now been updated and expanded . Importantly, these guidelines have been endorsed by international MS societies [8, 31], yet we still know very little about the safety profile of exercise among persons with MS. This is particularly important, as healthcare providers have seemingly been reluctant in prescribing exercise training for clinical management of MS , with evidence indicating that this may, in part, be because there is limited comprehensive understanding of the risk profile of this behaviour . The recent surge in exercise training studies in MS  further underscores the need to identify the safety profile on this salient intervention in MS.
Relapse risk, adverse events (AE), and serious adverse events (SAE) [33, 34] indicate the construct of safety in MS clinical study, and we describe these terms in Table 1. To date, only three reviews have considered the safety of exercise training for MS [35,36,37]. The most comprehensive included 26 RCTs published up until November 2013 . That study reported that people with MS receiving a form of exercise intervention had lower rates of relapse equating to approximately 27% lower relapse rate for exercise training versus non-exercise control conditions. Notably, the rate of other AE across studies was higher in the exercise as represented by a 67% higher risk of AE from exercise. In terms of AE, 22 of the 26 RCTs recorded dropout rate, and this is important as another indicator of intervention feasibility; the mean dropout rate across studies was 15.2% for control group participants and 15.5% for exercise training participants.
Another review included safety outcomes as a sub-analysis during a review of the efficacy of physical interventions in MS . That systematic review included three additional studies to the focal review in 2014, and authors provided a narrative commentary of AE, relapse, and dropout rate. One more recent systematic review focused on high-intensity aerobic interval training in MS, and inclusive of studies up to September 2017 noted the reporting of no AE in six of the seven included studies . However, the authors did not provide an analytical review of safety constructs. One other systematic review and meta-analysis of AE reported AE and SAE across 16 different health conditions, with MS investigated as part of the Neurological subgroup . The authors established that in neurological conditions, there is a decreased risk of non-serious AE when participating in exercise training interventions. Our review in 2014 identified a need for more transparent recording and reporting of safety outcomes in MS exercise training studies , and we highlighted a lack of transparent reporting of exercise training protocols and variability in exercise prescriptions. Our contemporaries recently noted that reporting of training protocols is improving . However, those researchers did not take analytical approaches to compare safety between and across exercise interventions. There has been no clear distinction between SAE and non-serious AE. Such distinctions are of high importance as we judge the severity of any event and focus on the likely attribution exercise training may have on relapse, SAE, or AE in MS. A review of safety in randomised controlled exercise training studies in MS will allow fair comparison, and our planned review will focus on relapse, SAE, and AE as primary outcomes.
Today, alongside the increasing number of clinical exercise trials in MS , there has been a move towards exercise prescription at vigorous intensities, through the medium of interval training  (defined in Table 1), as an example. There is an urgent need to build on what is already known about the safety of exercise in MS, particularly to closely focus on the contemporary research published after that important review. To date, the focus on intervention characteristics, such as exercise type, delivery style (e.g., supervised, independent, or remotely supervised), participant disability level (e.g., mild, moderate, or severe, as determined via, e.g., the Expanded Disability Status Scale ), or the prescription of exercise consistent with minimal exercise guidelines for persons with MS [19, 29], have not been considered in terms of safety. Establishing the safety profile of exercise interventions at this level will offer greater clarity in intervention delivery and assist with providing data on the feasibility of the exercise guidelines.
The comprehensive review of the safety of exercise training must further include information on retention rates, alongside adherence to attending the intervention and compliance with the prescribed exercise of the intervention. Recently, one study has taken a meta-analytical approach to identify adherence and study completion rates in 41 MS exercise training studies. That study identified a pooled estimate of adherence at 0.73 (CI 0.68–0.78) when including participants who did not complete the study . The authors indicated that further work is warranted to identify the influencing factors on retention and adherence; our review will provide essential data on the relationship between outcomes of safety and retention, adherence, and compliance to exercise interventions, and therefore, address the request of these authors.
The proposed systematic review builds on our previous review considering publications from 2013 onward to (a) quantify the relative risk of relapses, AE, SAE, and dropout (i.e., retention rate) for exercise conditions compared to non-exercise comparison conditions; and (b) provide a proxy measure of participation with exercise training among persons with MS by considering intervention retention, adherence, and compliance. Secondary aims will include exploration of potential sources of variability in overall relative risk, including variables of theoretical, practical, and/or prior empirical relation to exercise interventions, such as (c) exercise types, (d) exercise delivery styles, and (e) disability levels (defined in Table 1 and based on established disability cut-points ), and (f) prescription of exercise training consistent with the minimal exercise guidelines for persons with mild to moderate MS [19, 29], and we will examine year of publication as a variable in the overall effect. We will further identify the reporting of rates of relapse, rates of adverse effects (refer to Table 1, these are AE directly reported as attributable to the intervention), serious adverse effects (refer to Table 1, these are AE directly reported as attributable to the intervention), retention, adherence to attending the exercise training, and compliance with the prescribed exercise training in randomised controlled trials.
The protocol will adhere to the Preferred Reporting Items for Systematic review and Meta-Analysis Protocol) statement . An original review by the research team  was a basis for the current review. The protocol for the review is registered with the International Prospective Register of Systematic Reviews (PROSPERO 2020 CRD42020190544). As detailed in the authors’ previously published systematic reviews [43,44,45], standard methods will be used for data extraction, data synthesis and meta-analysis, and meta-regression analysis. In addition, the Participants, Interventions, Comparisons, and Outcomes (PICO) strategy was adapted to suit the scope of the review and used to guide the search strategy . In brief, and described in detail in the search strategy and Table 1, the terms were persons with Multiple Sclerosis (Participants) and Exercise training (Intervention). The comparison is non-exercise and non-pharmacological comparator, and relapse, AE, and SAE are the main outcomes.
The inclusion criteria are as follows: a randomised controlled trial (RCT) design with reporting of safety outcomes overall and per condition during the study; adults (aged 18 years or above) with multiple sclerosis; an intervention type which meets the definition of exercise training . All non-active/non-exercise control conditions will be considered, for example, “usual activity, non active education programme”. Further, data derived from articles included in our original review  will be included.
The following exclusion criteria will be applied: studies not written in English, non-human participants, physical interventions which are primarily sedentary (e.g., manual therapy, breathing exercises, pelvic floor exercises), control interventions which are pharmacology based.
Search strategy and information sources
A university librarian will assist the research team in the development of the search strategy, and this librarian will undertake the database searches. The following databases will be searched for reports of trials of exercise training in persons with MS: Ovid MEDLINE All, Ovid Embase, ProQuest PsycINFO, Cochrane Central Register of Controlled Trials (CENTRAL), Ebsco CINAHL, Scopus, Web of Science Core Collection (CC), and PEDro–Physiotherapy Evidence. All databases are recommended as core database for our field on inquiry .
Search terms will include free text keywords and relevant subject headings, and there will be no language restrictions in the automated search (we will remove non-English language articles during article screening). All databases will be searched from 2013 to present, following completion of the search in November 2013 for our original review. As the relevant search engines do not allow a search of exact months, we will hand search any relevant publications from 2013 to ascertain if published in November/December 2013. Supplementary material 1 comprises the proposed Medline search strategy.
We will further search the reference lists of included studies and relevant systematic reviews for studies meeting our inclusion criteria. Further, to identify the most recent data, we will (1) search international clinical trial registers for recently completed trials, including the Australian and New Zealand Clinical Trials Registry, European Union Clinical Trials Register (EudraCT), International Standard Randomised Controlled Trial Number, US Clinical Trials Register, and the WHO Portal, and make attempts to identify published studies (e.g., contacting authors); (2) we will use Scopus and Web of Science to undertake forward citation searches for studies which fit our inclusion criteria; we will use the studies identified in our primary search and selection criteria, above, as the base of our forward citation search; (3) we will run our search strategy prior to submission of our manuscript for publication.
Data management and extraction
Data will be managed during the screening and data extraction process using Covidence (https://www. covidence. org) and Microsoft Excel. Two review authors will independently screen the titles and abstracts of search results for relevance; we will acquire full texts of relevant articles, and two review authors will then screen these for relevance independently. Where full text cannot be acquired, we will contact the authors of relevant studies and request published or draft manuscripts. Throughout the process, a third author will assist in resolving screening conflicts.
Data, described in Table 1, will be extracted from relevant articles by two authors working independently. Data will be extracted into a study-specific database (Microsoft Excel file), and we will include a data dictionary and instructions for extracting researchers. Extracting researchers will receive training and pilot the database with a minimum of four studies each prior to formal extraction. Discrepancies will be resolved by adjudication by raters after any necessary recoding.
Risk of bias
Two authors will independently assess study quality, via risk of bias, in the studies, per the PEDro scale . The use of the PEDro tool will (1) cement comparison between pre-2014 and contemporary studies and (2) allow an overall narrative comment on reporting and study quality in studies reporting safety data. This data will be entered into the aforementioned database. Descriptive domains in the PEDro tool assess the external validity of the results (i.e., eligibility criteria) and the quality of the trial (i.e., randomisation, concealed group allocation, baseline similarities of groups, subject blinding, therapist blinding, assessor blinding, key outcomes attained from 85% of the sample, intention to treat analysis, statistics compared for at least one key outcome, and statistics compared at more than one time-point). Consistent with the literature on the use of the PEDro rating mechanism , we will score each study on 10 of the 11 criteria, with the criterion involving eligibility criteria not being included in the overall score. We will categorise higher quality studies as studies with a PEDro score of ≥ 6 and lower quality studies as studies with a PEDro score of <6 . We will judge the rater agreement on study quality with Kappa . Discrepancies will be resolved by adjudication by raters after any necessary recoding.
The primary outcomes of interest for the review are (1) relapse, (2) AE, and (3) SAE. Secondary outcomes are (4) dropout/retention and (5) adherence/compliance. We define all terms in Table 1.
Per group, we will quantify the number of relapses and, separately, the number and type of AE and SAE. Reporting AE and adverse effects together will allow comparison between previous results  and those reported in studies published after November 2013. We will provide a descriptive analysis and narrative description of adverse effects and serious adverse effects where possible. Similarly, we will report retention as the number of completing participants per groups. We will provide descriptive data on adherence and compliance to the intervention, in the intervention groups only.
We will undertake a narrative synthesis and critical appraisal based on the risk of bias per PEDro scores, and we will make a narrative comment on the difference in safety reporting based on study quality. We will further consider a narrative synthesis of participant characteristics (e.g., type of MS and years since diagnosis) to describe and identify the clinical and policy implications of our findings.
Analyses will be conducted using SPSS (IBM SPSS v24; MeanES and MetaReg macros) and Stata (Stata Corp v14; meta).
Calculation of relative risk
Overall, we will calculate the relative risk of each of our three primary outcomes and retention into the study compared with control conditions. The unit of analysis for each of our three outcomes is the total number of relapses, adverse events, or serious adverse events experienced in each group of each study. For example, the overall rate of relapse, defined as the total number of reported relapses in the exercise and control conditions (i.e., number of relapses in each condition by the total number in each condition), will be pooled across all studies, respectively. We will calculate the overall relative risk of relapse using standard risk procedures, that is a ratio of rates, or the ratio of participants in a treatment group who experience an illness, condition, or event (i.e., relapse) to those in a control group who experience the same illness, condition, or event . We will calculate relative risk by dividing the overall rate of relapse, AEs, SAEs, or dropout for exercise by the overall rate of relapse, AEs, SAEs, or dropout, respectively, in the control condition. A relative risk of 1.0 would indicate no difference in risk of the outcome between exercise and control conditions. A relative risk above 1.0 would indicate a higher risk of events with exercise training, and a relative risk below 1.0 would indicate a lower risk of events with exercise training. We will only report data from studies that directly report on the presence or absence of relapse or events. We will use standard procedures  to calculate relative risk, its standard error, and 95% confidence interval. Where zeros create problems with computation of relative risk or standard errors, we will add 0.5 to all cells (e.g., exercise relapse, exercise non-relapse, control relapse, and control non-relapse) [53, 54].
Data synthesis and analysis
Using an SPSS MeanES macro , a random-effects model will be used to aggregate mean relative risk for each of the primary outcomes. Based on established methods , we will calculate Cochrane Q and I2 to evaluate heterogeneity and consistency, respectively. In addition, sampling error will be calculated using Cochrane’s Q according to established methods; heterogeneity will be indicated if sampling error accounts for less than 75% of the observed variance and when p<0.05 for Q . I2 values of 25%, 50%, and 75% will indicate small, moderate, and large amounts of heterogeneity, respectively . Forest plots will be generated to illustrate the distribution of each effect size weighted by its inverse variance. Funnel plots will be generated and visually inspected, and Egger’s regression  and Begg’s rank correlation will be conducted to examine risk of publication bias . The number needed to treat for an additional harmful outcome (NNTH), expressed as a function of absolute risk, will be calculated to express the number of participants engaged in exercise training for which one additional adverse outcome (i.e., relapse, AE, SAE, or dropout) may be expected .
Random-effects models will be used to calculate the mean relative risk and 95% CIs for each level of moderator variables  or potential sources of variability in the mean relative risk that are of logical, theoretical, and/or prior empirical relation to exercise training among persons with MS. Where data permits (i.e., where there are three or more effects for levels of the moderator variable), moderators will be included in random-effects univariate meta-regression analysis with maximum likelihood estimation using the SPSS macro MetaReg . Meta-regression offers the benefit of concurrent estimates of independent effects by multiple moderators on the variation in relative risk across trials. Tests of the regression model (QR) and its residual error (QE) will be reported. If meta-analysis is not possible for a given outcome based on fewer than three effects, a narrative synthesis of included study results will be performed that appraises reported outcomes, study characteristics and methodological procedures which may have contributed to reported results, and the quality of included studies.
Our updated review of the safety of exercise interventions in MS will pool relapse, AE, and SAE events in RCTs published since November 2013. Since 2013, there has been a dramatic increase in the number of clinical exercise studies in MS  and a change in study design, for example, exercise intervention type (e.g., vigorous intensity interval training)  and intervention delivery (e.g., remotely supervised exercise training). This highlights a need to further clarify safety. In addition, since the publication of minimal exercise guidelines for exercise in MS in 2013 [19, 29], there is a need to make comment on the comparative safety reporting in studies prescribing these guidelines. Focal review of interventions delivering the exercise guidelines has not been undertaken; this is fundamental to the clinical promotion of these guidelines. We will compare previous literature on exercise training safety in MS [35,36,37], and with our planned review of retention rates, intervention adherence rates, and intervention compliance rates, we will confirm recent meta-analyses . Our protocol provides a systematic and robust approach to determining the safety of exercise training in a clinical population and has high utility for repetition in other clinical populations such as stroke, Parkinson’s disease, and other populations where exercise prescription is a management strategy.
This review will be the first to consider exercise training safety when comparing participant characteristics (i.e., disability level). Identification of exercise training safety will be informative for persons with MS, for clinicians, and MS advocacy groups when providing lifestyle behaviour recommendations, for clinicians and researchers when considering intervention delivery and design, and for funding bodies and policy-makers when considering the impact of research applications.
Limitation of this systematic review and meta-analysis include the potential heterogeneity of research methodology that we expect to find in the included studies which will impact our choice of data analysis. In addition, reporting of outcomes may limit possible analyses. Where our planned analyses are inappropriate, we will proceed with narrative synthesis. We will report any deviation to the protocol in the full review.
Availability of data and materials
Physiotherapy Evidence Database risk of bias
Randomised controlled trial
Serious adverse event
Compston A, Coles A. Multiple sclerosis. Lancet. 2002;372(9648):1502–17.
GMS Collaborators. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 - The Lancet Neurology. Lancet Neurol. 2019;18(3):269–85.
King R. Atlas of MS 3rd edition. PART 1: mapping multiple sclerosis around the world key epidemiology findings. London: Multiple Sclerosis International Federation; 2020.
Wilkins LW. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019 Oct 8;93(15):688. https://doi.org/10.1212/WNL.0000000000007915.
Kobelt G, Thompson AJ. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017;23(8):1123–36. https://doi.org/10.1177/1352458517694432.
Benito-Leon J, Martinez-Martin P. Health-related quality of life in multiple sclerosis. Neurologia. 2003;18(4):210–7.
Motl RW, McAuley E, Sandroff BM, Hubbard EA. Descriptive epidemiology of physical activity rates in multiple sclerosis. Acta Neurol Scand. 2015;131(6):422–5. https://doi.org/10.1111/ane.12352.
Kalb R, Brown TR, Coote S, Costello K, Dalgas U, Garmon E, et al. Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Multiple Sclerosis Journal. 2020;Early online DOI 10.1177/1352458520915629.
Dalgas U, Hvid LG, Kwakkel G, Motl RW, de Groot V, Feys P, et al. Moving exercise research in multiple sclerosis forward (the MoXFo initiative): developing consensus statements for research. Multiple Sclerosis Journal. 2020;Early online, DOI 10.1177/1352458520910360.
Dunn M, Bhargava P, Kalb R. Your patients with multiple sclerosis have set wellness as a high priority-and the National Multiple Sclerosis Society is responding. US Neurology. 2015;11(2):80–6. https://doi.org/10.17925/USN.2015.11.02.80.
McCabe M. A needs analysis of Australians with MS: Multiple Sclerosis Research Australia; 2012.
National Institute for Health and Clinical Excellence. 2018 surveillance of multiple sclerosis in adults: management (NICE guideline G186). 2018.
Richardson EV, Fifolt M, Barstow E, Silveira SL, Sikes EM, Motl RW. The priorities of neurologists for exercise promotion in comprehensive multiple sclerosis care - ScienceDirect. Multiple Sclerosis and Related Disorders. 2020;38:e101482.
Motl RW, Sandroff BM, Kwakkel G, Dalgas U, Feinstein A, Heesen C, et al. Exercise in patients with multiple sclerosis. The Lancet Neurology. 2017;16(10):848–56. https://doi.org/10.1016/S1474-4422(17)30281-8.
Pearson M, Dieberg G, Smart N. Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: a meta-analysis. Arch Phys Med Rehabil. 2015;96(7):1339–48. https://doi.org/10.1016/j.apmr.2015.02.011.
Learmonth YC, Ensari I, Motl RW. Physiotherapy and walking outcomes in adults with multiple sclerosis: systematic review and meta-analysis. Phys Ther Rev. 2016;21(3–6):160–72. https://doi.org/10.1080/10833196.2016.1263415.
Paltamaa J, Sjögren T, Peurala SH, Heinonen A. Effects of physiotherapy interventions on balance in multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials. J Rehabil Med. 2012;44(10):811–23. https://doi.org/10.2340/16501977-1047.
Sandroff BM, Motl RW, Scudder MR, DeLuca J. Systematic, evidence-based review of exercise, physical activity, and physical fitness effects on cognition in persons with multiple sclerosis. Neuropsychol Rev. 2016;26(3):271–94. https://doi.org/10.1007/s11065-016-9324-2.
Latimer-Cheung AE, Pilutti LA, Hicks AL, Martin Ginis KA, Fenuta A, Mackibbon KA, et al. The effects of exercise training on fitness, mobility, fatigue, and health related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development. Arch Phys Med Rehabil. 2013;94(9):1800–28. https://doi.org/10.1016/j.apmr.2013.04.020.
Dalgas U, Stenager E, Sloth M, Stenager E. The effect of exercise on depressive symptoms in multiple sclerosis based on a meta-analysis and critical review of the literature. Eur J Neurol. 2015;22(3):443–e34. https://doi.org/10.1111/ene.12576.
Ensari I, Motl R.W., Pilutti LA. Exercise training improves depressive symptoms in people with multiple sclerosis: results of a meta-analysis. J Psychosom Res 2014;76(6):465–471, DOI: https://doi.org/10.1016/j.jpsychores.2014.03.014.
Adamson BC, Ensari I, Motl RW. The effect of exercise on depressive symptoms in adults with neurological disorders: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96(7):1329–38. https://doi.org/10.1016/j.apmr.2015.01.005.
Leavitt VM, Cirnigliaro C, Cohen A, Farag A, Brooks M, Wecht JM, et al. Aerobic exercise increases hippocampal volume and improves memory in multiple sclerosis: preliminary findings. Neurocase. 2014;20(6):695–7. https://doi.org/10.1080/13554794.2013.841951.
Sandroff BM, Johnson CL, Motl RW. Exercise training effects on memory and hippocampal viscoelasticity in multiple sclerosis: a novel application of magnetic resonance elastography. Neuroradiology. 2017 Jan;59(1):61–7. https://doi.org/10.1007/s00234-016-1767-x.
Pilutti LA, Dlugonski D, Sandroff BM, Klaren R, Motl RW. Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis. Mult Scler. 2014 Apr;20(5):594–601. https://doi.org/10.1177/1352458513503391.
Sadeghi Bahmani D, Kesselring J, Papadimitriou M, Bansi J, Pühse U, Gerber M, et al. In patients with multiple sclerosis, both objective and subjective sleep, depression, fatigue, and paresthesia improved after 3 weeks of regular exercise. Front Psychiatry. 2019;3(10):265.
Ranadive SM, Yan H, Weikert M, Lane AD, Linden MA, Baynard T, et al. Vascular dysfunction and physical activity in multiple sclerosis. Med Sci Sports Exerc. 2012;44(2):238–43. https://doi.org/10.1249/MSS.0b013e31822d7997.
Wens I, Eijnde B, Hansen D. Muscular, cardiac, ventilatory and metabolic dysfunction in patients with multiple sclerosis: implications for screening, clinical care and endurance and resistance exercise therapy, a scoping review - ScienceDirect. J Neurol Sci. 367:107–21.
Latimer-Cheung AE, Martin Ginis KA, Hicks AL, Motl R, Pilutti L, Duggan M, et al. Development of evidence-informed physical activity guidelines for adults with multiple sclerosis. Arch Phys Med Rehabil. 2013;94(9):1829–36. https://doi.org/10.1016/j.apmr.2013.05.015.
Kim Y, Lai B, Mehta T, Thirumalai M, Padalabalanarayanan S, Rimmer JH, et al. Exercise training guidelines for multiple sclerosis, stroke, and Parkinson disease: rapid review and synthesis. Am J of Phys Med & Rehab. 2019 Jul;98(7):613–21. https://doi.org/10.1097/PHM.0000000000001174.
Zarghami A, Taylor B, Marck CH, van der Mei I. Marie Pangan Lo L, Black L, et al. Multiple Sclerosis Research Australia: Modifiable lifestyle factors and MS. A guide for health professionals; 2020.
Motl RW, Learmonth YC, Pilutti LA, Gappmaier E, Coote S. Top 10 research questions related to physical activity and multiple sclerosis. Res Q Exerc Sport. 2015;16(2):117–29.
Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, et al. PRISMA harms checklist: improving harms reporting in systematic reviews. Br Med J. 2016;352:i157.
Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000 Oct 7;356(9237):1255–9. https://doi.org/10.1016/S0140-6736(00)02799-9.
Pilutti LA, Platta ME, Motl RW, Latimer-Cheung AE. The safety of exercise training in multiple sclerosis: a systematic review. J Neurol Sci. 2014;343(1–2):3–7. https://doi.org/10.1016/j.jns.2014.05.016.
Coulter EH, Bond S, Dalgas U, Paul L. The effectiveness of interventions targeting physical activity and/or sedentary behaviour in people with multiple sclerosis: a systematic review. Disabil Rehabil. 2020;42(5):594–612. https://doi.org/10.1080/09638288.2018.1503737.
Campbell E, Coulter EH, Paul L. High intensity interval training for people with multiple sclerosis: a systematic review. Mult Scler Relat Disord. 2018 Aug;24:55–63. https://doi.org/10.1016/j.msard.2018.06.005.
Niemeijer A, Lund H, Stafne SN, Ipsen T, Goldschmidt CL, Jørgensen CT, et al. Adverse events of exercise therapy in randomised controlled trials: a systematic review and meta-analysis. Br J Sports Med. 2019;early online.
Platta ME, Ensari I, Motl RW, Pilutti LA. Effect of exercise training on fitness in multiple sclerosis: a meta-analysis. Arch Phys Med Rehabil. 2016;97(9):1564–72. https://doi.org/10.1016/j.apmr.2016.01.023.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–52. https://doi.org/10.1212/WNL.33.11.1444.
Dennett R, Madsen L, Connolly L, Hosking J, Dalgas U, Freeman J. Adherence and drop-out in randomized controlled trials of exercise interventions in people with multiple sclerosis: a systematic review and meta-analyses - ScienceDirect. 2020;43:early online.
Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995;45(2):251–5. https://doi.org/10.1212/WNL.45.2.251.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71.
McDowell CP, Dishman RK, Gordon BR, Herring MP. Physical activity and anxiety: a systematic review and meta-analysis of longitudinal studies. Am J Prev Med. 2019;57(4):545–56. https://doi.org/10.1016/j.amepre.2019.05.012.
Gordon BR, McDowall CP, Hallgren M, Meyer JD, Lyons M, Herring MP. Association of efficacy of resistance exercise training with depressive symptoms: a meta-analysis and meta-regression analysis of randomized clinical trials. JAMA Psychiatry. 2018;75(6):566–76. https://doi.org/10.1001/jamapsychiatry.2018.0572.
Gordon BR, McDowall CP, Lyons M, Herring MP. The effects of resistance exercise training on anxiety: a meta-analysis and meta-regression analysis of randomized controlled trials. Sports Med. 2017;47(12):2521–32. https://doi.org/10.1007/s40279-017-0769-0.
Santos CMDC, Pimenta CADM, Nobre MRC. The PICO strategy for the research question construction and evidence search. Revista Latino-Americana de Enfermagem. 2007;15(3):508–11. https://doi.org/10.1590/S0104-11692007000300023.
Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985 Apr;100(2):126–31.
Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH. Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Systematic reviews. 2017;6(1):245. https://doi.org/10.1186/s13643-017-0644-y.
Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003 Aug;83(8):713–21. https://doi.org/10.1093/ptj/83.8.713.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. biometrics. 1977;159–74.
Maher JM, Markey JC, Ebert-May D. The other half of the story: effect size analysis in quantitative research. CBE Life Sci Educ. 2013;12(3):345–51. https://doi.org/10.1187/cbe.13-04-0082.
Altman DG. Practical statistics for medical research. London: Chapman and Hall; 2001.
Pagano M, Gaureau K. Principles of biostatistics. 2nd ed. Brooks/Cole: Belmont, CA; 2000.
Deeks J, Higgins J. Statistical algorithms in Review Manager 5 [Internet]. 2010. Available from: http://ims.cochrane.org/
Lipsey M, Wilson D. Practical meta-analysis, vol. 49. Thousand Oaks, CA: SAGE Publications Ltd; 2001.
Higgins J, Thomas J, Chandler J, Cumpston M, Tianjing L, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions. 6.2. Available from www.training.cochrane.org/handbook.; 2021.
Hedges L, Olkin I. Statistical methods for meta-analysis. San Diego, CA: Academic Press; 1985.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101. https://doi.org/10.2307/2533446.
Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Bmj. 1995;310(6977):452–4. https://doi.org/10.1136/bmj.310.6977.452.
Riebe D, Ehrman JK, Liguori G, Magal M. ACSM’s guidelines for exercise testing and prescription. 10th ed. Sydney: Wolters Kluwer/Lippincott Williams & Wilkins; 2018.
Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR, Salem GJ, et al. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009 Jul;41(7):1510–30. https://doi.org/10.1249/MSS.0b013e3181a0c95c.
Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee I-M, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011 Jul;43(7):1334–59. https://doi.org/10.1249/MSS.0b013e318213fefb.
Warburton DER, Nicol CW, Bredin SSD. Health benefits of physical activity: the evidence. Can Med Assoc J. 2006 Mar 14;174(6):801–9. https://doi.org/10.1503/cmaj.051351.
Berkovich R. Treatment of acute relapses in multiple sclerosis. Neurotherapeutics. 2012 Dec 11;10(1):97–105.
Chakrabarti S. What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014 Jun 22;4(2):30–6. https://doi.org/10.5498/wjp.v4.i2.30.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Learmonth, Y.C., Pilutti, L.A., Herring, M.P. et al. Safety of exercise training in multiple sclerosis: a protocol for an updated systematic review and meta-analysis. Syst Rev 10, 208 (2021). https://doi.org/10.1186/s13643-021-01751-0
- Multiple sclerosis
- Adverse event
- Serious adverse event